Medexus reports strong fiscal Q2 2027 results driven by record GRAFAPEX product performance
FROM THE WIRE · NEWSFILECORP.COM
Fiscal Q2 2027 net revenue of $29.1 million, Adjusted EBITDA* of $5.1 million, operating income of $2.4 million, and net income of $0.8 million - all quarterly records since fiscal Q4 2025, demonstrating significant year-over-year growth Product-level net revenue* from GRAFAPEX™…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRecord quarterly results for a small pharma company, with revenue and net income growing.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Fiscal Q2 2027 net revenue was $29.1 million.
- 02Adjusted EBITDA was $5.1 million and net income was $0.8 million.
- 03GRAFAPEX product-level net revenue was $5.7 million, also a quarterly record.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets